Accumulation of 99mTc-ciprofloxacin in Staphylococcus aureus and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2691-2692

  Sierra, J M ^a,b   Rodriguez Puig, D ^a   Soriano, A ^a   Mensa, J ^a   Piera, C ^a   Vila, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; CIPROFLOXACIN TC 99M; PERTECHNETIC ACID TC 99M; PROTEIN MEX AB OPRM; PROTEIN NORA; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEXA PROTEIN, PSEUDOMONAS AERUGINOSA; MEXB PROTEIN, PSEUDOMONAS AERUGINOSA; MULTIDRUG RESISTANCE PROTEIN; NORA PROTEIN, STAPHYLOCOCCUS; OPRM PROTEIN, PSEUDOMONAS AERUGINOSA; OUTER MEMBRANE PROTEIN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M CIPROFLOXACIN;

ARTICLE; BACTERIAL STRAIN; BIOACCUMULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RADIOACTIVITY; SEPSIS; STAPHYLOCOCCUS AUREUS; BACTERIAL GENE; GENE EXPRESSION; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; METABOLISM; MICROBIOLOGY; SCINTISCANNING; STAPHYLOCOCCUS INFECTION;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CIPROFLOXACIN; GENE EXPRESSION; GENES, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RADIOPHARMACEUTICALS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 46249105282     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00217-08     Document Type: Article

References (11)

1. Conejo, M. C., L. Martinez-Martinez, I. García, L. Picabea, and A. Pascual. 2003. Effect of siliconized latex urinary catheters on the activity of carbapenems against P. aeruginosa strains with defined mutations in ampC, oprD, and genes coding for efflux systems. Int. J. Antimicrob. Agents 22:122-127.
2. Kaatz, G. W., and S. M. Seo. 1997. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 41:2733-2737.
3. Malamitsi, J., H. Giamarellou, K. Kanellakopoulou, E. Dounis, V. Grecka, J. Christakopoulos, G. Koratzanis, A. Antoniadou, G. Panoutsopoulos, C. Batsakis, and C. Proukakis. 2003 Infection: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection. Clin. Microbiol. Infect. 9:101-109.
4. Martinez-Martinez, L., I. Garcia, M. C. Conejo, P. Joyanes, and A. Pascual. 2000. Accumulation of b-lactams and quinolones into bacteria cells, p. 63-72. In V. J. Benedi, R. Canton, M. A. Dominguez, L. Martinez, and J. Vila (ed.), Antimicrobial resistance: a laboratory approach. Biomerieux, Madrid, Spain.
5. Piddock, L. V. J. 1997. Mechanism of quinolone uptake into bacterial cells. J. Antimicrob. Chemother. 27:399-403.
6. Rodriguez-Puig, D., C. Piera, D. Fuster, A. Soriano, J. M. Sierra, S. Rubi, and J. Suades. 2006. A new method of [99mTc]-ciprofloxacin preparation and quality control. J. Labelled Comp. Radiopharm. 49:1171-1176.
7. Ruiz, J. 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51:1109-1117.
8. Sarda, L., A. C. Cremieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Genin, N. Delahaye, D. Huten, and D. Le Guludec. 2003. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J. Nucl. Med. 44:920-926.
9. Sierra, J. M., J. G. Cabeza, M. Ruiz Chaler, T. Montero, J. Hernandez, J. Mensa, M. Llagostera, and J. Vila. 2005. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae Clin. Microbiol. Infect. 8:750-758.
10. Sierra, J. M., F. Marco, J. Ruiz, M. T. Jimenez de Anta, and J. Vila. 2002. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and resistant Staphylococcus aureus. Clin. Microbiol. Infect. 8:781-790.
11. Welling, M. M., A. Paulusma-Annema, H. S. Balter, E. K. Pauwels, and P. H. Nibbering. 2000. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur. J. Nucl. Med. 27:292-301.